Syncing Global Regulatory Filings Across FDA, EMA, and PMDA with AJ Acker

The podcast explores strategies for life science companies to navigate global regulatory filings across the U.S., Europe, and Japan. AJ Acker, a veteran in the rare diseases and biotech space, highlights key differences between the FDA, EMA, and PMDA, noting their varying priorities and data requirements. Acker emphasizes the importance of early planning and engagement with regulatory bodies to align on clinical endpoints and development strategies. The discussion covers common pitfalls in data package preparation, the role of local regulatory experts, and the prioritization of submissions across different markets. Acker also shares examples of successful global filings, such as Hymbrula helimbra and Zolgensma, and touches on the potential of AI in streamlining submission processes.